Financial burden of hospital-acquired Clostridium difficile infection.

Clostridium difficile infection has become endemic in many hospitals and yet few data on the associated costs of such cases are available. We prospectively followed 50 consecutive cases of C. difficile infection and 92 control patients, who were admitted to the same geriatric wards within 72 h of the cases. Cases and controls had similar age, sex and major diagnosis distributions. Cases stayed significantly longer (mean 21.3 days, median 20.5 days; P < 0.001) in hospital than controls, including an average 14 days in a side room. Diarrhoea developed in cases on average 10.8 days after admission, which, when compared with a mean duration of stay for controls of 25.2 days, implies that C. difficile infection caused an increased duration of stay, as opposed to infection occurring because of longer residence. There was a significantly higher death rate in cases compared with controls (P < 0.01). Antibiotic treatment of C. difficile infection cost an average of Pounds 47 per case. The average number of laboratory investigations per day was similar for cases and controls, but the increased length of stay meant an extra cost for tests of approximately Pounds 210 per case. Assuming hotel costs of Pounds 150 (Pounds 200) per day stay (in a side room), 94% of the additional costs associated with C. difficile infection were due to increased duration of stay (Pounds 3850). The total identifiable increased cost of C. difficile infection was, therefore, in excess of Pounds 4000 per case. Such high costs can be used to justify expenditure on personnel and/or other control measures to reduce the incidence of this hospital-acquired infection.

[1]  R. Spencer,et al.  Clostridium difficile infection: responses, relapses and re-infections. , 1992, The Journal of hospital infection.

[2]  S. Mehtar How to cost and fund an infection control programme. , 1993, The Journal of hospital infection.

[3]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[4]  L. Peterson,et al.  Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. , 1986, Archives of internal medicine.

[5]  D. Gerding,et al.  PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.

[6]  D. McCann,et al.  Management and control of a large outbreak of diarrhoea due to Clostridium difficile. , 1994, The Journal of hospital infection.

[7]  L. Peterson,et al.  Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. , 1989, The Journal of infectious diseases.

[8]  L. Rosen,et al.  Clostridium difficile—A common and costly colitis , 1991, Diseases of the colon and rectum.

[9]  A. MacGowan,et al.  Clostridium difficile-associated diarrhoea and length of hospital stay , 1995 .

[10]  D. Gordon,et al.  Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. , 1985, The American journal of gastroenterology.

[11]  K. D. Allen,et al.  Costs of an outbreak of wound infections in an orthopaedic ward. , 1992, The Journal of hospital infection.

[12]  J. Bartlett,et al.  Postantibiotic Colonization with Clostridium difficile in Nursing Home Patients , 1990, Journal of the American Geriatrics Society.

[13]  L. Peterson,et al.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. , 1992, The Journal of infectious diseases.

[14]  T. Riley,et al.  Increased length of hospital stay due to Clostridium difficile associated diarrhoea , 1995, The Lancet.

[15]  M. Wilcox,et al.  Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. , 1995, The Journal of antimicrobial chemotherapy.

[16]  T. Riley,et al.  Relapse versus reinfection with Clostridium difficile , 1991, Epidemiology and Infection.